Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain

A series of fused tricyclic mGluR1 antagonists containing a pyridone ring were synthesized. In vitro, these antagonists were potent against both human and rat isozymes, as well as selective for inhibiting mGluR1 over mGluR5. When dosed orally, several examples were active in vivo in a rat SNL test.

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 22; no. 4; pp. 1575 - 1578
Main Authors Bennett, Chad E., Burnett, Duane A., Greenlee, William J., Knutson, Chad E., Korakas, Peter, Li, Cheng, Tulshian, Deen, Wu, Wen-Lian, Bertorelli, Rosalia, Fredduzzi, Silva, Grilli, Mariagrazia, Lozza, Gianluca, Reggiani, Angelo, Veltri, Alessio
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 15.02.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of fused tricyclic mGluR1 antagonists containing a pyridone ring were synthesized. In vitro, these antagonists were potent against both human and rat isozymes, as well as selective for inhibiting mGluR1 over mGluR5. When dosed orally, several examples were active in vivo in a rat SNL test.
Bibliography:http://dx.doi.org/10.1016/j.bmcl.2011.12.131
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2011.12.131